Found: 5
Select item for more details and to access through your institution.
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00890-4
- By:
- Publication type:
- Article
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0286925
- By:
- Publication type:
- Article
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00451-7
- By:
- Publication type:
- Article
Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.838504
- By:
- Publication type:
- Article
Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis.
- Published in:
- NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0136-2
- By:
- Publication type:
- Article